Homework: E-Prescribing
E-prescribing is the transmission of prescription or prescription-related information using electronic media between a prescriber, dispenser, pharmacy benefit manager, or health plan, either directly or through an intermediary, including an e-prescribing network.
In an effort to understand the benefits and cautions about e-prescribing, conduct thorough research. For your homework, create a 4- to 6 pages report in Microsoft Word document consisting of your research findings covering your responses to the following questions:
1. Evaluate three pros and three cons of e-prescribing.
2. Summarize the e-prescription standards as described by the National Council for Prescription Drug Programs.
3. Evaluate the projected cost and time savings as estimated by the United States Department of Health and Human Services.
4. Comment on the controversy surrounding the 2013 e-prescribing penalty.
Format your homework according to the give formatting requirements:
• The answer must be using Times New Roman font (size 12), double spaced, typed, with one-inch margins on all sides.
• The response also includes a cover page containing the student's name, the title of the homework, the course title, and the date. The cover page is not included in the required page length.
• Also include a reference page. The references and Citations should follow APA format. The reference page is not included in the required page length.
Reference
• Ratanawongsa, N., Lenny L. S. Chan, Fouts, M. M., & Murphy, E. J. (2017). The challenges of electronic health records and diabetes electronic prescribing: Implications for safety net care for diverse populations. Journal of Diabetes Research, 2017 doi:10.1155/2017/8983237
• Juszczyk, D., Charlton, J., McDermott, L., Soames, J., Sultana, K., Ashworth, M., . . . Gulliford, M. C. (2016). Electronically delivered, multicomponent intervention to reduce unnecessary antibiotic prescribing for respiratory infections in primary care: A cluster randomized trial using electronic health records-REDUCE trial study original protocol. BMJ Open, 6(8)